In Vitro and in Vivo Activities of Antimicrobials against Nocardia brasiliensis

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 3, 2004, Pages 832-837

  Gomez Flores, Alejandra ^a   Welsh, Oliverio ^a   Said Fernández, Salvador ^b   Lozano Garza, Gerardo ^b   Tavarez Alejandro, Roman Erick ^a   Vera Cabrera, Lucio ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFAMANDOLE; CEFEPIME; CEFOTIAM; CEFOXITIN; CEFPIROME; CEFSULODIN; CEFTAZIDIME; CEFTIOFUR; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; GENTAMICIN; ISEPAMICIN; LATAMOXEF; LINEZOLID; MACROLIDE; MINOCYCLINE; NETILMICIN; NITROXOLINE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; SPIRAMYCIN; TOBRAMYCIN; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DILUTION; FEMALE; MEXICO; MOUSE; MYCETOMA; NOCARDIA BRASILIENSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FOOT; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; NOCARDIA; NOCARDIA INFECTIONS; SKIN DISEASES, INFECTIOUS;

EID: 1442300143     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.3.832-837.2004     Document Type: Article

References (39)

1. Alos, J. I. 2003. Quinolones. Enferm. Infecc. Microbiol. Clin. 21:261-268. (In Spanish.)
2. Ambaye, A., P. C. Kohner, P. C. Wollan, K. L. Roberts, G. D. Roberts, and F. D. Cockerill. 1997. Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex. J. Clin. Microbiol. 35:847-852.
3. Bach, M. C., L. D. Sabath, and M. Finland. 1982. Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob. Agents Chemother. 22:554-559.
4. Berkey, P., D. Moore, and K. Rolston. 1988. In vitro susceptibilities of Nocardia species to newer antimicrobial agents. Antimicrob. Agents Chemother. 32:1078-1079.
5. Boiron, P., and F. Provost. 1982. In vitro susceptibility testing of Nocardia spp. and its taxonomic implication. J. Antimicrob. Chemother. 22:623-629.
6. Brown-Elliott, B. A., and R. J. Wallace. 1992. Broth microdilution MIC test for Nocardia spp., p. 5.12.1-5.12.7. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook, vol. 1. American Society for Microbiology, Washington, D.C.
7. Brown-Elliott, B. A., S. C. Ward, C. J. Crist, L. B. Mann, R. W. Wilson, and R. J. Wallace. 2001. In vitro activities of linezolid against multiple Nocardia species. Antimicrob. Agents Chemother. 45:1295-1297.
8. Eliopoulos, G. M., and R. C. Moellering. 1996. Antimicrobial combinations, p. 330-396. In V. Lorian (ed,), Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
9. Gomez, A., A. Saul, A. Bonifaz, and M. Lopez. 1993. Amoxicillin and clavulanic acid in the treatment of actinomycetoma. Int. J. Dermatol. 32:218-220.
10. González-Ochoa, A., J. Shields, and P. Vázquez. 1952. Acción Acción de la 4-4 diamino-difenil-sulfona frente a Nocardia brasiliensis (estudios in vitro en la infección experimental y en clínica). Gac. Med. Mex. 52:345-353.
11. González-Ochoa, A. 1955. Effectiveness of DDS in the treatment of chromoblastomycosis and of mycetoma caused by Nocardia brasiliensis, p. 321-327. In Therapy of fungus diseases, an international symposium. Little, Brown & Co., Boston, Mass.
12. González Ochoa, A. 1969. Producción experimental del micetoma por Nocardia brasiliensis en el ratón. Gac. Med. Mex. 99:773-781.
13. Hoban, D. J. 1989. Comparative in vitro activity of quinolones. Clin. Investig. Med. 12:10-13.
14. Jensen, K. T., H. Schonheyder, C. Pers, and V. F. Thomsen. 1992. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources. APMIS 100:543-552.
15. Lavalle, P., A. Saul, and J. Peniche. 1961. La sulfadimetoxipiridazina en el tratamiento de los micetomas, p. 525-535. In I Congress of Mexican Dermatology, Mexico City, Mexico.
16. Lavalle, P. 1966. Clinical aspects and therapy of mycetoma. Dermatol. Int. 5:117-120. (In Spanish.)
17. López-Martínez, R., L. J. Méndez-Tovar, P. Lavalle, O. Welsh, A. Saul, and E. Macotela-Ruiz. 1992. Epidemiología del micetoma en México: estudio de 2105 casos. Gac. Med. Mex. 128:477-481.
18. Mahgoub, E. S. 1972. Treatment of actinomycetoma with sulfamethoxazole plus trimethoprim. Am. J. Trop. Med. Hyg. 21:332-335.
19. Mahgoub, E. S. 1976. Medical management of mycetoma. Bull. W. H. O. 54:303-311.
20. McNeil, M. M., J. M. Brown, W. R. Jarvis, and L. Ajello. 1990. Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens. Rev. Infect. Dis. 12:778-783.
21. Mingeot-Leclercq, M. P., and P. M. Tulkens. 1999. Aminoglycosides: nephrotoxicity. Antimicrob. Agents Chemother. 43:1003-1012.
22. Mishra, S. K., R. E. Gordon, and D. A. Barnett. 1980. Identification of nocardiae and streptomycetes; of medical importance. J. Clin. Microbiol. 11:728-736.
23. Moylett, E. H., S. E. Pacheco, B. A. Brown-Elliott, T. R. Perry, E. S. Buescher, M. C. Birmingham, J. J. Schentag, J. F. Gimbel, A. Apodaca, M. A. Schwartz, R. M. Rakita, and R. J. Wallace, Jr. 2003. Clinical experience with linezolid for the treatment of Nocardia infection. Clin. Infect. Dis. 36:313-318.
24. NCCLS. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A. NCCLS, Wayne, Pa.
25. Ndiaye, B., M. Develoux, M. A. Langlade, and A. Kane. 1994. Actinomycotic mycetoma. A propos of 27 cases in Dakar; medical treatment with cotrimoxazole. Ann. Dermatol. Venereol. 121:161-165.
26. Nolt, D., R. M. Wadowsky, and M. Green. 2000. Lymphocutaneous Nocardia brasiliensis infection: a pediatric case cured with amoxicilin/clavulanate. Pediatr. Infect. Dis. J. 19:1023-1025.
27. Pigrau, C. 2003. Oxazolidinones and glycopeptides. Enferm. Infecc. Microbiol. Clin. 21:157-164. (In Spanish.)
28. Steingrube, V. A., R. J. Wallace, B. A. Brown, Y. Pang, B. Zeluff, L. C. Steele, and Y. Zhang. 1991. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid. Antimicrob. Agents Chemother. 35:524-528.
29. Valera, L., E. Gradelski, E. Huczko, T. Washo, H. Yigit, and J. Fung-Tomc. 2002. In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates. J. Antimicrob. Chemother. 50:140-142.
30. Vera-Cabrera, L., A. Gomez-Flores, W. G. Escalante-Fuentes, and O. Welsh. 2001. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis. Antimicrob. Agents Chemother. 45: 3629-3630.
31. Wallace, R. J., E. J. Septimus, D. M. Musher, and R. R. Martin. 1977. Disk diffusion susceptibility testing of Nocardia species. J. Infect. Dis. 135:568-576.
32. Wallace, R. J., K. Wiss, R. Curvey, P. H. Vance, and J. Steadham. 1983. Differences among Nocardia spp. in susceptibility to aminoglycosides and beta-lactam antibiotics and their potential use in taxonomy. Antimicrob. Agents Chemother. 23:19-21.
33. Wallace, R. J., D. R. Nash, W. K. Johnson, L. C. Steele, and V. A. Steingrube. 1987. β-Lactam resistance in Nocardia brasiliensis is mediated by β-lactamase and reversed in presence of clavulanic acid. J. Infect. Dis. 156:959-966.
34. Wallace, R. J., Jr., and L. C. Steele. 1988. Susceptibility testing of Nocardia species for the clinical laboratory. Diagn. Microbiol. Infect. Dis. 9:155-166.
35. Wallace, R. J., Jr., L. C. Steele, G. Sumter, and J. M. Smith. 1988. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob. Agents Chemother. 32:1776-1779.
36. Welsh, O., E. Sauceda, J. Gonzalez, and J. Ocampo. 1987. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J. Am. Acad. Dermatol. 17:443-448.
37. Welsh, O. 1991. Mycetoma: current concepts in treatment. Int. J. Dermatol. 30:387-398.
38. Wilson, R. W., V. A. Steingrube, B. A. Brown, Z. Blacklock, K. C. Jost, Jr., A. McNabb, W. D. Colby, J. R. Biehle, J. L. Gibson, and R. J. Wallace, Jr. 1997. Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis. J. Clin. Microbiol. 35:2235-2242.
39. Wortman, P. D. 1993. Treatment of Nocardia brasiliensis mycetoma with sulfamethoxazole and trimethoprim, amikacin and amoxicillin and clavulanate. Arch. Dermatol. 129:564-567.